Company intelligence / Profile preview

Changsha Tuoyang Pharmaceutical Technology

Changsha, Hunan, China

Ownership: Private
Development stage: Other

Overview

Changsha Tuoyang Pharmaceutical Technology is a Chinese biotechnology company focused on the research and development of innovative small molecule therapeutics for metabolic diseases. The company specializes in the discovery of treatments for type 2 diabetes and obesity, with a particular emphasis on incretin-based therapies and glucose transporters. Based in Changsha, Hunan Province, the firm operates within the regional high-tech industrial development zones to advance its early-stage pipeline. Its activities encompass drug design, synthesis, and preclinical evaluation of novel chemical entities.

Therapeutic areas: EndocrinologyMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Changsha Tuoyang Pharmaceutical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Changsha Tuoyang Pharmaceutical Technology.

Explore the full profile